Journal of Cutaneous Oncology

Official Journal of the Society of Cutaneous Oncology

[Journal of Cutaneous Oncology @CutaneousOnc]

Hot off the press in Perspectives on the Science (JoCO):
"Nivolumab Plus Ipilimumab in Merkel Cell Carcinoma" delves into dual checkpoint blockade and its promising impact on MCC outcomes.
👉 Read more: https://t.co/3a0qaC0sLV
#MCC #Immunotherapy #NivoIpi #DermOnc #JoCO

[Journal of Cutaneous Oncology @CutaneousOnc]

New in Perspectives on the Science (JoCO):
"The Evolving Role of Circulating Tumor DNA in Merkel Cell Carcinoma" explores how ctDNA is reshaping disease monitoring, prognosis, and potentially guiding treatment.
🧬 Read the full piece: https://t.co/mdz1F8gXdq
#MCC #ctDNA #JoCO

[Journal of Cutaneous Oncology @CutaneousOnc]

Tumor-Infiltrating lymphocyte #TIL therapy is a new FDA-approved option for patients with advanced #melanoma. In this #JoCO editorial, the authors reflect on the recent approval of the first cellular therapy for melanoma.
https://t.co/oFqOWSxzCk

[Journal of Cutaneous Oncology @CutaneousOnc]

Is routine skin cancer screening recommended for all? Check out this Perspectives on the Science article to find out more: https://t.co/5yhYAA3GFX

#skincancer

[Journal of Cutaneous Oncology @CutaneousOnc]

Merkel Cell Carcinoma is a rare skin cancer with the potential for recurrence and poor patient outcomes. Check out this Perspectives on the Science article that examines the role of post-operative immunotherapy for MCC: https://t.co/yZLBHgbOnO

[Journal of Cutaneous Oncology @CutaneousOnc]

Moh's surgery is one option for patients with invasive melanoma. Check out this Perspectives on the Science article to read more about it: https://t.co/haFB49ErnD

[Journal of Cutaneous Oncology @CutaneousOnc]

Does more frequent surveillance imaging improve patient outcomes in stage III melanoma? Check out the Perspectives on the Science article by Kevin Emerick and @TheMillerLab https://t.co/6UGWysvTUa.

[Journal of Cutaneous Oncology @CutaneousOnc]

What’s the latest data on Mohs surgery for invasive melanoma? Check out this Perspectives on the Science piece in #JoCO https://t.co/QhXYsjjnlw
#Melanoma #Cancer #mohs #derm

[Journal of Cutaneous Oncology @CutaneousOnc]

Is adjuvant anti-PD1 ready for the clinic for patients with Merkel Cell Carcinoma? Check out the latest #JoCO Perspectives on the Science.

https://t.co/7AwdBZ66TB

#MCC #Immunotherapy #Cancer

[Med Learning Group @MLG_CME]

Explore Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer with leading experts Dr. Miller @TheMillerLab and Dr.Patel!

Register now for Monday, June 26th at 7:00 PM ET: https://t.co/McQQNIFgsg

#Virtual #CME #Immunotherapy #MedTwitter #MedLearningGroup

[Society of Cutaneous Oncology @SocCutaneousOnc]

Thx to Laura Ferris, Nikhi Khushalani, Kevin Emerick, Sonia Cohen, Sameer Gupta, Ryan Sullivan, @bosques12, @EmilyKimMed, @BhatiaS_MD, @MunTheLoon & @TheMillerLab for another great Journal Club discussion of the @USPSTF recs re: skin cancer screening
https://t.co/MZhcNvO3pd

[R Medicine @r_medicine]

David Miller & Sophia Shalhout with @MGHMedicine & @MassEyeAndEar, will be giving a session presentation on “StoryboardR: An R package and Shiny application designed to visualize real-world data from clinical patient registries” at #RMed2023. #Rstats ➡️ https://t.co/jBqgzg0gfF

[Medscape @Medscape]

You still have time to join us live from #ASCO23!

Learn and earn credit from social media. Watch the stream now.

[Med Learning Group @MLG_CME]

🎉 The excitement is building as we count down for our Complimentary Virtual CME/CNE Program on NMSC!

Join Dr. Miller @TheMillerLab and Dr. Patel TONIGHT at 7:30 PM EST!

Register Now: https://t.co/b1BJqMu161

#oncology #MedTwitter #VirtualEvent #CME #CNE #MedLearningGroup

[David M. Miller MD, PhD, FAAD @TheMillerLab]

Looking forward to discussing the latest developments in the treatment of #NMSC with Dr. Vishal Patel of GW med at tonight’s @MLG_CME event.

[David Michael Miller, MD, PhD, FAAD @Dave_M_Miller]

Thanks @MedscapeLIVE for another fantastic event on #immunotherapy and #skincancer. Really enjoyed learning from @KYTsaiLab and Dr. Michael Migden. Great having the inimitable Dr. Michael Wong fielding questions on the real-time virtual forum.

[David M. Miller MD, PhD, FAAD @TheMillerLab]

Excited for the upcoming #RMed2023. Always one of my favorite events of the year. Looking forward to presenting StoryboardR - An R Package and Shiny Application Designed to Visualize Real-World Data From Clinical Patient Registries with @SophiaShalhout.
#Rstats @r_medicine

[David M. Miller MD, PhD, FAAD @TheMillerLab]

Looking forward to hearing from our esteemed panelists @KYTsaiLab and Dr. Michael Migden along with co-chair Dr. Michael K Wong in our upcoming @MedscapeLIVE event:
https://t.co/Lkvyyp59lC
It should make for a great discussion.

[Med Learning Group @MLG_CME]

Explore the latest melanoma therapies and the significant role of anti-LAG3 antibodies with Dr. Miller @TheMillerLab!

Learn more about this activity: https://t.co/7i8WIWGCBI

#SkinCancerAwareness #Melanoma #immunotherapy #CME #medicaleducation #medlearninggroup